Product Name : Enfuvirtide powder (T-20)
Synonyms Enfuvirtide; T-2;Enfuvirtide Acetate (T-20);ENFUVIRTIDE(T-20)
98+%;Enfurvitide(T-20);Pentafuside;Ac-Tyr-Thr-Ser-Leu-Ile-His-Ser-Leu-Ile-Glu-Glu-Ser-Gln-Asn-Gln-Gln-Glu-Lys-Asn-Glu-Gln-Glu-Leu-Leu-Glu-Leu-Asp-Lys-Trp-Ala-Ser-Leu-Trp-Asn-Trp-Phe-NH{2};Enfuvirtide;Aids059486
CAS No. 159519-65-0
Molecular Formula : C204H301N51O64
Molecular Weight : 4491.92
EINECS No.:1533716-785-6
Density : 1.59g/cm3
Single Impurity (HPLC) : 0.5%max
Amino Acid Composition : ±10% of theoretical
Peptide Content (N%) : ≥80.0%
Water Content (Karl Fischer) : ≤8.0%
TrifluoroAcetate Content(HPIC) : ≤12.0%
MS (ESI) : Consistent
Mass Balance : 95.0~105.0%
Appearance : White freeze-dried powder
Purity : 99%
Quality Standard: Enterprise standard
Storage Conditions : -20°C
Packing :5mg/vial
Shipment : EMS;DHL;FedEx;TNT;UPS
Delivery Time : 3-5 Working Days
Payment terms : T/T;Western Union;Money Gram;Bitcoin
Enfuvirtide is an antiretroviral drug used in combination therapy for
the treatment of HIV-1/AIDS. It binds to the first heptad-repeat (HR1)
in the gp41 subunit of the viral envelope glycoprotein and prevents the
conformational changes required for the fusion of viral and cellular
membranes. It works by disrupting the HIV-1 molecular machinery at the
final stage of fusion with the target cell, preventing uninfected cells
from becoming infected.
Applications:
Enfuvirtide (INN) is an HIV fusion inhibitor, the first of a novel class
of antiretroviral drugs used in combination therapy for the treatment
of HIV-1 infection. It is marketed under the trade name Fuzeon (Roche).
